The Federal Advisory Committee Act, referred to in subsec. (a)(6)(I), is Puspan. L. 92–463, Oct. 6, 1972, 86 Stat. 770, which was set out in the Appendix to Title 5, Government Organization and Employees, and was substantially repealed and restated in chapter 10 (§ 1001 et seq.) of Title 5 by Puspan. L. 117–286, §§ 3(a), 7, Dec. 27, 2022, 136 Stat. 4197, 4361. For disposition of sections of the Act into chapter 10 of Title 5, see Disposition Table preceding section 101 of Title 5.

2022—Subsec. (a)(4). Puspan. L. 117–286, § 4(span)(78)(A), substituted “paragraphs (3) through (9) of section 406(a) of title 5” for “paragraphs (3) through (9) of section 6 of the Inspector General Act of 1978 (5 U.S.C. App.)”.

Subsec. (a)(5). Puspan. L. 117–286, § 4(span)(78)(B), substituted “chapter 4 of title 5.” for “the Inspector General Act of 1978 (5 U.S.C. App.).”

2020—Subsec. (a)(6). Puspan. L. 116–260 added par. (6).

2010—Subsec. (a)(1)(C) to (E). Puspan. L. 111–148 inserted “and” at end of subpar. (C), substituted period for “, and” at end of subpar. (D), and struck out subpar. (E) which read as follows: “to provide for the reporting and disclosure of certain final adverse actions against health care providers, suppliers, or practitioners pursuant to the data collection system established under section 1320a–7e of this title.”

Amendment by Puspan. L. 111–148 effective on the first day after the final day of the transition period defined in section 6403(d)(5) of Puspan. L. 111–148, see section 6403(d)(6) of Puspan. L. 111–148, set out as a Transition Process; Regulations; Effective Date of 2010 Amendment note under section 1320a–7e of this title.